BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533
FDA Device Recall #Z-0400-2024 — Class II — October 4, 2023
Recall Summary
| Recall Number | Z-0400-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 4, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton Dickinson Infusion Therapy Systems Inc. |
| Location | Sandy, UT |
| Product Type | Devices |
| Quantity | 528,000 |
Product Description
BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533
Reason for Recall
Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and repeat catheter insertion attempts, due to catheter being inadvertently removed from the insertion site.
Distribution Pattern
US Nationwide distribution in the states of CA, NC, MI, WA, CO, FL, NJ, NM, IL, KY, TN, OH, TX, IN, LA, IA, MS, MO, NE, MD, NY, PA, GA, VA, ME, SC, RI, MA, PR.
Lot / Code Information
UDI-DI: 00382903825332, Lot: 3166524, Expiration: 2026/05/31
Other Recalls from Becton Dickinson Infusion Therapy Sys...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0025-2024 | Class II | REF: 386862, BD Cathena Safety IV catheter with... | Aug 29, 2023 |
| Z-0174-2023 | Class II | BD Nexiva Closed IV Catheter System - Single Po... | Oct 12, 2022 |
| Z-0306-2022 | Class II | BD Nexiva, 20 GA 1.00 IN (1.1 X 25 mm), 3660 ml... | Sep 8, 2021 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.